Immunome Inc.
IMNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472012
In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 8 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Immunome Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- 0 vs. Q2 2023
- Shares held
- 2.36M
- +413.9K (+21.2%) vs. Q2 2023
- Total value
- $19.7M
- +$4.23M (+27.4%) vs. Q2 2023
- New holders
- 9
- 6 more added
- Sold out
- 9
- 10 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMNM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 202 | $2.50B |
| Q1 2026 | 202 | $2.54B |
| Q4 2025 | 183 | $2.54B |
| Q3 2025 | 153 | $1.07B |
| Q2 2025 | 142 | $738.7M |
| Q1 2025 | 143 | $518.4M |
| Q4 2024 | 121 | $566.3M |
| Q3 2024 | 115 | $754.7M |
| Q2 2024 | 114 | $578.4M |
| Q1 2024 | 103 | $903.6M |
| Q4 2023 | 57 | $229.9M |
| Q3 2023 | 35 | $19.7M |
| Q2 2023 | 35 | $15.4M |
| Q1 2023 | 30 | $9.34M |
| Q4 2022 | 28 | $4.85M |
| Q3 2022 | 24 | $10.7M |
| Q2 2022 | 26 | $7.78M |
| Q1 2022 | 29 | $15.4M |
| Q4 2021 | 30 | $36.4M |
| Q3 2021 | 35 | $58.3M |
| Q2 2021 | 29 | $41.1M |
| Q1 2021 | 31 | $64.7M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Immunome Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 545,919 | $4.56M | 0.02% | +127,792+30.6% | Added |
| Vanguard Group Inc | 396,329 | $3.31M | 0.00% | +22,451+6.0% | Added |
| Alpine Global Management, LLC | 365,971 | $3.06M | 0.70% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 173,630 | $1.45M | 0.00% | +173,630 | New |
| TD Asset Management Inc | 127,280 | $1.06M | 0.00% | +127,280 | New |
| Prentice Capital Management, LP | 112,131 | $936.3K | 2.88% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 84,708 | $707.5K | 0.00% | +3,495+4.3% | Added |
| Bank of Montreal | 92,593 | $692.6K | 0.00% | −7,741−7.7% | Reduced |
| Manufacturers Life Insurance Company, The | 53,746 | $448.8K | 0.00% | +53,746 | New |
| Acadian Asset Management LLC | 49,712 | $414.0K | 0.00% | +49,712 | New |
| BlackRock Inc. | 42,529 | $355.1K | 0.00% | −783−1.8% | Reduced |
| Renaissance Technologies LLC | 32,400 | $271.0K | 0.00% | −12,100−27.2% | Reduced |
| State Street Corp | 29,591 | $247.1K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 29,091 | $242.9K | 0.00% | −36,915−55.9% | Reduced |
| Royal Bank of Canada | 28,556 | $239.0K | 0.00% | −241−0.8% | Reduced |
| Magnus Financial Group LLC | 25,759 | $215.1K | 0.03% | 00.0% | Unchanged |
| Baldwin Investment Management, LLC | 25,394 | $212.0K | 0.04% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 25,129 | $209.8K | 0.00% | +7,665+43.9% | Added |
| HighTower Advisors, LLC | 18,818 | $157.0K | 0.00% | +3,000+19.0% | Added |
| Schonfeld Strategic Advisors LLC | 18,201 | $152.0K | 0.00% | +18,201 | New |
| Northern Trust Corp | 16,465 | $137.5K | 0.00% | −245−1.5% | Reduced |
| Dimensional Fund Advisors LP | 15,433 | $128.9K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 14,939 | $124.0K | 0.00% | −1,865−11.1% | Reduced |
| Morgan Stanley | 12,155 | $101.5K | 0.00% | −1,311−9.7% | Reduced |
| Wealth Architects, LLC | 11,110 | $92.8K | 0.02% | 00.0% | Unchanged |
| Citadel Advisors LLC | 7,493 | $62.6K | 0.00% | +6,394+581.8% | Added |
| Dorsey Wright & Associates | 3,100 | $25.9K | 0.01% | +3,100 | New |
| MB, Levis & Associates, LLC | 2,373 | $19.8K | 0.01% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,848 | $15.4K | 0.00% | −9−0.5% | Reduced |
| Cubist Systematic Strategies, LLC | 299 | $2.50K | 0.00% | +299 | New |
| Newbridge Financial Services Group, Inc. | 225 | $1.88K | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 100 | $835 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 54 | $451 | 0.00% | +54 | New |
| UBS Group AG | 14 | $117 | 0.00% | −1,044−98.7% | Reduced |
| Qube Research & Technologies Ltd | 10 | $84 | 0.00% | +10 | New |
| Cerity Partners LLC | 0 | $0 | 0.00% | −67,126−100.0% | Sold out |
| Sterling Investment Advisors, Ltd. | 0 | $0 | 0.00% | −21,627−100.0% | Sold out |
| Heron Bay Capital Management | 0 | $0 | 0.00% | −13,139−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −7,705−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,040−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −915−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −600−100.0% | Sold out |